STAT+: Enliven Therapeutics' leukemia drug shows promise in new study
Reported bySTAT News ↗·Sourced by Goodlede
A targeted leukemia drug from Enliven Therapeutics demonstrated molecular responses in nearly half of advanced leukemia patients in new clinical data, representing a potential therapeutic advance for a difficult-to-treat cancer.
This does not prove the drug will be approved, is safe long-term, or will improve overall survival rates; early-stage responses do not guarantee clinical benefit or cure.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at STAT News
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Human Feats
Father and Son Break Three World Records in 18,000 Mile Cycle Around the World
Good News Network · Caution
Science & Health
Evidence that 40Hz gamma stimulation promotes brain health is expanding
MIT News · Verified
Equality
Women prepare for 'space jobs that don't exist yet'
BBC Science & Environment · Caution